Influenza Diagnostics Market Size Worth $ 1,205.15 Million By 2026 | CAGR: 9.4%

The global Influenza Diagnostics market size is expected to reach USD 1, 205.15 million by 2026 according to a new study by WhipSmart MI Research. The report “By Test Type Analysis (Traditional Diagnostic Tests, and Molecular Diagnostic Tests); By End User Analysis (Hospitals & Clinics, Reference Laboratories) and By Regions, Segments & Forecast, 2019 - 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The unique COVID impact assessor from WhipSmart MI takes inputs such as economic growth forecasts, industry outlooks, analyses churned out by various global agencies such as IMF, World Bank, OECD along with covid indicators such as infection rates, death rates, vaccine news to assess how the growth rate for markets will change over the next two years – 2020 & 2021. These dashboards are updated every quarter and are available for 4000+ markets.

The healthcare system is consistently being challenged to supply good quality health care. Aging populations, diminishing resources, budget restraint, and lack of ordinary devised clinical SOPs and treatment regimens are a number of the key factors that have fueled demand for quality care.

Increase in demand to curtail healthcare costs and therefore the increasing patient volume, because of the rising prevalence of chronic diseases. Additionally, the implementation of Influenza Diagnostics enhances patient care and safety, and alongside the govt initiatives for HCIT adoption, are driving the expansion of the market.

Hospitals and medical settings are within the process of integrating workflows of tedious documentation, medical and administrative staff management alongside quick access to the patient’s clinical and administrative data altogether the departments. Furthermore, multi modal hospitals got to share the info with their branch offices thus rising usage of interoperable quality solutions. A rise in demand for improved clinician productivity and patient-centered healthcare delivery from caregivers is bolstering the demand for these systems.

In the global Influenza Diagnostics market, North America dominated the marketplace for Influenza Diagnostics in 2018. Factors like, increasing number of R&D activities and patient admission within the hospitals resulting in high volume of knowledge entry are anticipated to impel regional growth. Additionally, increasing government initiatives regarding effective usage of interoperability, EHR, and other solutions and increasing specialize in patient care are driving the marketplace for Influenza Diagnostics within the region. Moreover, rising healthcare spending on digitization for secure exchange of knowledge within organizations, supports the marketplace for Influenza Diagnostics with the most important revenue contribution.

The key players in the market Hill-Rom Holdings, Inc. (US), Ascom Holding AG (Switzerland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Cisco Systems, Inc. (US), Stanley Black & Decker, Inc. (US), Cerner Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), and McKesson Corporation (US) among others. Development of distribution channels, novel product development and aggressive marketing campaigning are some of the success factors in the industry.

WhipSmart MI Market research has segmented the Influenza Diagnostics market report on the basis of test type, end-user and region

Influenza Diagnostics Test Type Outlook (Revenue, USD Million, 2019 – 2026)
Traditional
RIDT
Viral Culture
DFA
Serological Assays
Molecular
RT-PCR
NASBA
LAMP
SAMBA
Other Molecular Diagnostic Tests

Influenza Diagnostics End-User Outlook (Revenue, USD Million, 2019 – 2026)
Hospitals/Clinical Laboratories
Reference Laboratories
Other End User

Influenza Diagnostics Regional Outlook (Revenue, USD Million, 2019 – 2026)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Russia
Asia Pacific
Japan
Korea
Latin America
Mexico
Brazil
Colombia
Middle East & Africa
Saudi Arabia
Israel

Contact:
7264 Magistrate Terrace, Mississauga, Ontario L5W 1H8, Canada
+1 5102005090
sales@whipsmartmi.com

About Whipsmart MI:
Whipsmart MI provides fact based consulting services in the B2B and B2C domains to help assess complex VUCA developments and provide strategic intelligence to achieve transformational growth by identifying niche high growth opportunities. We facilitate the growth journey through a unique approach using a multitude of inputs to assess changes in the marketplace, disruptive trends, technologies, whitespaces and adjacencies across industries that will eventually impact respective industry domains.
WhipSmart Market Bytes is the most affordable market and competitive intelligence platform with accurate comprehensive coverage and quarterly updates, an indispensable market and strategy planning asset in a world of constant flux.

This release was published on openPR.